Cancer of the cervix uteri

International Journal of Gynecology and Obstetrics

Volumn 119, Issue SUPPL. 2, 2012, Pages

  Wiebe, Ericka ^a   Denny, Lynette ^b   Thomas, Gillian ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; NAVELBINE; PACLITAXEL; PLATINUM DERIVATIVE; TAXANE DERIVATIVE; TOPOTECAN;

ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL PROTOCOL; COLPOSCOPY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE METASTASIS; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE FRACTIONATION; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

EID: 84866645937     PISSN: 00207292     EISSN: 18793479     Source Type: Journal    
DOI: 10.1016/S0020-7292(12)60023-X     Document Type: Article

References (128)

1. DM Parkin, F Bray, J Ferlay, P Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2 2005 74 108
2. FIGO Committee on Gynecologic Oncology Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium Int J Gynecol Obstet 105 2 2009 103 104
3. LD Roman, JC Felix, LI Muderspach, A Agahjanian, D Qian, CP Morrow Risk of residual invasive disease in women with microinvasive squamous cancer in a conization specimen Obstet Gynecol 90 5 1997 759 764
4. H Hricak, C Gatsonis, DS Chi, MA Amendola, K Brandt, LH Schwartz et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183 J Clin Oncol 23 36 2005 9329 9337
5. S Bipat, AS Glas, J van der Velden, AH Zwinderman, PM Bossuyt, J Stoker Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review Gynecol Oncol 91 1 2003 59 66
6. H Hricak, KK Yu Radiology in invasive cervical cancer AJR Am J Roentgenol 167 5 1996 1101 1108
7. LL Subak, H Hricak, CB Powell, L Azizi, JL Stern Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging Obstet Gynecol 86 1 1995 43 50
8. J Kodama, Y Mizutani, A Hongo, M Yoshinouchi, T Kudo, H Okuda Optimal surgery and diagnostic approach of stage IA2 squamous cell carcinoma of the cervix Euro J Obstet Gynecol Reproductive Biol 101 2 2002 192 195
9. PW Grigsby, BA Siegel, F Dehdashti Lymph node staging by positron emission tomography in patients with carcinoma of the cervix J Clin Oncol 19 17 2001 3745 3749
10. WT Yang, WW Lam, MY Yu, TH Cheung, C Metreweli Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma AJR Am J Roentgenol 175 3 2000 759 766
11. LJ Havrilesky, SL Kulasingam, DB Matchar, ER Myers FDG-PET for management of cervical and ovarian cancer Gynecol Oncol 97 1 2005 183 191
12. PG Rose, LP Adler, M Rodriguez, PF Faulhaber, FW Abdul-Karim, F Miraldi Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study J Clin Oncol 17 41 1999 41 45
13. H Sakurai, Y Suzuki, T Nonaka, H Ishikawa, M Shioya, H Kiyohara et al. FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy - tumor volume and FDG uptake value Gynecol Oncol 100 3 2006 601 607
14. T-C Yen, K-K Ng, S-Y Ma, HH Chou, CS Tsai, S Hsueh et al. Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer J Clin Oncol 21 19 2003 3651 3658
15. H Hertel, C Köhler, T Elhawary, W Michels, M Possover, A Schneider Laparoscopic staging compared with imaging techniques in the staging of advanced cervical cancer Gynecol Oncol 87 1 2002 46 51
16. PT Ramirez, A Jhingran, HA Macapinlac, ED Euscher, MF Munsell, RL Coleman et al. Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings Cancer 117 9 2011 1928 1934
17. S Marnitz, C Köhler, C Roth, J Füller, W Hinkelbein, A Schneider Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer? Gynecol Oncol 99 3 2005 536 544
18. MA Gold, C Tian, CW Whitney, PG Rose, R Lanciano Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study Cancer 112 9 2008 1954 1963
19. PB Heller, JH Maletano, BN Bundy, DR Barnhill, T Okagaki Clinical-pathologic study of stage IIB, III, and IVA carcinoma of the cervix: extended diagnostic evaluation for paraaortic node metastasis - a Gynecologic Oncology Group study Gynecol Oncol 38 3 1990 425 430
20. SB Edge, DR Byrd, CC Compton, AG Faiz, FL Greene, A Trotti Gynecologic Sites. AJCC Cancer Staging Manual 7th ed. 2010 Springer New York, London 395 402
21. WK Kinney, EV Egorshin, DJ Ballard, KC Podratz Long-term survival and sequelae after surgical management of invasive cervical carcinoma diagnosed at the time of simple hysterectomy Gynecol Oncol 44 1 1992 24 27
22. AG Ostör Studies on 200 cases of early squamous cell carcinoma of the cervix Int J Gynecol Pathol 12 3 1993 193 207
23. SW Lee, Y-M Kim, W-S Son, HJ You, DY Kim, JH Kim et al. The efficacy of conservative management after conization in patients with stage IA1 microinvasive cervical carcinoma Acta Obstet Gynecol Scand 88 2 2009 209 215
24. F Mota Microinvasive squamous carcinoma of the cervix: treatment modalities Acta Obstet Gynecol Scand 82 6 2003 505 509
25. JC Webb, CR Key, CR Qualls, HO Smith Population-based study of microinvasive adenocarcinoma of the uterine cervix Obstet Gynecol 97 5 Pt-1 2001 701 706
26. P Elliott, M Coppleson, P Russell, P Liouros, J Carter, C MacLeod et al. Early invasive (FIGO stage IA) carcinoma of the cervix: a clinico-pathologic study of 476 cases Int J Gynecol Cancer 10 1 2000 42 52
27. JH Shepherd, C Spencer, J Herod, TE Ind Radical vaginal trachelectomy as a fertility-sparing procedure in women with early-stage cervical cancer-cumulative pregnancy rate in a series of 123 women BJOG 113 6 2006 719 724
28. MA Quinn, JL Benedet, F Odicino, P Maisonneuve, U Beller, WT Creasman et al. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer Int J Gynecol Obstet 95 Suppl 1 2006 S43 103
29. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials J Clin Oncol 26 35 2008 5802 5812
30. F Landoni, A Maneo, A Colombo, F Placa, R Milani, P Perego et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer Lancet 350 9077 1997 535 540
31. PJ Eifel, M Morris, JT Wharton, MJ Oswald The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix Int J Radiat Oncol Biol Phys 29 1 1994 9 16
32. F Landoni, A Maneo, G Cormio, P Perego, R Milani, O Caruso et al. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study Gynecol Oncol 80 1 2001 3 12
33. HM Shingleton, SJ Soong, MS Gelder, KD Hatch, VV Baker, JM Austin Jr Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix Obstet Gynecol 73 6 1989 1027 1034
34. FN Rutledge, JP Smith, JT Wharton, AG O'Quinn Pelvic exenteration: analysis of 296 patients Am J Obstet Gynecol 129 8 1977 881 892
35. GW Morley, MP Hopkins, SM Lindenauer, JA Roberts Pelvic exenteration, University of Michigan: 100 patients at 5 years Obstet Gynecol 74 6 1989 934 943
36. R Estape, R Angioli Surgical management of advanced and recurrent cervical cancer Semin Surg Oncol 16 3 1999 236 241
37. T Benn, RA Brooks, Q Zhang, MA Powell, PH Thaker, DG Mutch et al. Pelvic exenteration in gynecologic oncology: a single institution study over 20 years Gynecol Oncol 122 1 2011 14 18
38. RC Boronow The bulky 6-cm barrel-shaped lesion of the cervix: primary surgery and postoperative chemoradiation Gynecol Oncol 78 3 Pt 1 2000 313 317
39. NF Hacker, GV Wain, JL Nicklin Resection of bulky positive lymph nodes in patients with cervical carcinoma Int J Gynecol Cancer 5 4 1995 250 256
40. R Kupets, GM Thomas, A Covens Is there a role for pelvic lymph node debulking in advanced cervical cancer? Gynecol Oncol 87 2 2002 163 170
41. PF van Bommel, AC van Lindert, HC Kock, WH Leers, JP Neijt A review of prognostic factors in early-stage carcinoma of the cervix (FIGO I B and II A) and implications for treatment strategy Eur J Obstet Gynecol Reprod Biol 26 1 1987 69 84
42. WA Peters, PY Liu, RJ Barrett, RJ Stock, BJ Monk, JS Berek et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 8 2000 1606 1613
43. M Rotman, A Sedlis, MR Piedmonte, B Bundy, SS Lentz, LI Muderspach et al. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study Int J Radiat Oncol Biol Phys 65 1 2006 169 176
44. A Sedlis, BN Bundy, MZ Rotman, SS Lentz, LI Muderspach, RJ Zaino A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study Gynecol Oncol 73 2 1999 177 183
45. M Follen, CF Levenback, RB Iyer, PW Grigsby, EA Boss, ES Delpassand et al. Imaging in cervical cancer Cancer 98 9 Suppl 2003 2028 2038
46. MS Piver, WS Chung Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma Obstet Gynecol 46 5 1975 507 510
47. C Levenback, RL Coleman, TW Burke, WM Lin, W Erdman, M Deavers et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy J Clin Oncol 20 3 2002 688 693
48. J Hauspy, M Beiner, I Harley, L Ehrlich, G Rasty, A Covens Sentinel lymph nodes in early stage cervical cancer Gynecol Oncol 105 2 2007 285 290
49. C Altgassen, H Hertel, A Brandstädt, C Köhler, M Dürst, A Schneider Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group J Clin Oncol 26 18 2008 2943 2951
50. JM Martínez-Palones, A Gil-Moreno, MA Pérez-Benavente, I Roca, J Xercavins Intraoperative sentinel node identification in early stage cervical cancer using a combination of radiolabeled albumin injection and isosulfan blue dye injection Gynecol Oncol 92 3 2004 845 850
51. J van de Lande, B Torrenga, PG Raijmakers, OS Hoekstra, MW van Baal, HA Brölmann et al. Sentinel lymph node detection in early stage uterine cervix carcinoma: a systematic review Gynecol Oncol 106 3 2007 604 613
52. L Gortzak-Uzan, W Jimenez, S Nofech-Mozes, N Ismiil, MA Khalifa, V Dubé et al. Sentinel lymph node biopsy vs. pelvic lymphadenectomy in early stage cervical cancer: is it time to change the gold standard? Gynecol Oncol 116 1 2010 28 32
53. E Barranger, C Coutant, A Cortez, S Uzan, E Darai Sentinel node biopsy is reliable in early-stage cervical cancer but not in locally advanced disease Ann Oncol 16 8 2005 1237 1242
54. C Coutant, AG Cordier, E Guillo, M Ballester, R Rouzier, E Daraï Clues pointing to simple hysterectomy to treat early-stage cervical cancer Oncol Rep 22 4 2009 927 934
55. M Frumovitz, CC Sun, KM Schmeler, MT Deavers, R Dos Reis, CF Levenback et al. Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer Obstet Gynecol 114 1 2009 93 99
56. MA Varia, BN Bundy, G Deppe, R Mannel, HE Averette, PG Rose et al. Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study Int J Radiat Oncol Biol Phys 42 5 1998 1015 1023
57. PW Grigsby, JD Lu, DG Mutch, RY Kim, PJ Eifel Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10 Int J Radiat Oncol Biol Phys 41 4 1998 817 822
58. W Small, LK Mell, P Anderson, C Creutzberg, J De Los Santos, D Gaffney et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer Int J Radiat Oncol Biol Phys 71 2 2008 428 434
59. JF Tierney, C Vale, P Symonds Concomitant and neoadjuvant chemotherapy for cervical cancer Clin Oncol (R Coll Radiol) 20 6 2008 401 416
60. L Rydzewska, J Tierney, CL Vale, PR Symonds Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer Cochrane Database Syst Rev 1 2010 CD007406
61. A Gadducci, S Cosio, P Zola, G Tisi, A Ferrero, E Piovano et al. Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study Int J Gynecol Cancer 20 8 2010 1399 1404
62. A Buda, R Fossati, N Colombo, F Fei, I Floriani, D Gueli Alletti et al. Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study J Clin Oncol 23 18 2005 4137 4145
63. P Benedetti-Panici, S Greggi, A Colombo, M Amoroso, D Smaniotto, D Giannarelli et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study J Clin Oncol 20 1 2002 179 188
64. PG Rose, BN Bundy, EB Watkins, JT Thigpen, G Deppe, MA Maiman et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 15 1999 1144 1153
65. CW Whitney, W Sause, BN Bundy, JH Malfetano, EV Hannigan, WC Fowler Jr et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study J Clin Oncol 17 5 1999 1339 1348
66. M Morris, PJ Eifel, J Lu, PW Grigsby, C Levenback, RE Stevens et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 15 1999 1137 1143
67. ZZ Lei, FZ He External cobalt 60 irradiation alone for stage IIB carcinoma of the uterine cervix Int J Radiat Oncol Biol Phys 16 2 1989 339 341
68. R Ferrigno, PE dos Santos Novaes, AC Pellizzon, MA Maia, RC Fogarolli, AC Gentil et al. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications Int J Radiat Oncol Biol Phys 50 5 2001 1123 1135
69. L Fenkell, M Assenholt, SK Nielsen, C Haie-Meder, R Pötter, J Lindegaard et al. Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer Int J Radiat Oncol Biol Phys 79 5 2011 1572 1579
70. JD Kochanski, LK Mell, JC Roeske, AJ Mundt Intensity-modulated radiation therapy in gynecologic malignancies: current status and future directions Clin Adv Hematol Oncol 4 5 2006 379 386
71. BD Kavanagh, TE Schefter, Q Wu, S Tong, F Newman, M Arnfield et al. Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer Semin Radiat Oncol 12 3 2002 260 271
72. S Nag, B Erickson, B Thomadsen, C Orton, JD Demanes, D Petereit The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix Int J Radiat Oncol Biol Phys 48 1 2000 201 211
73. X Wang, R Liu, B Ma, K Yang, J Tian, L Jiang et al. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer Cochrane Database Syst Rev 7 2010 CD007563
74. GK Rath, DN Sharma, PK Julka, V Subramani, A Bahl, KP Haresh Pulsed-doserate intracavitary brachytherapy for cervical carcinoma: the AIIMS experience Am J Clin Oncol 33 3 2010 238 241
75. Cl Rogers, JH Freel, BL Speiser Pulsed low dose rate brachytherapy for uterine cervix carcinoma Int J Radiat Oncol Biol Phys 43 1 1999 95 100
76. MC Tod, WJ Meredith A dosage system for use in the treatment of cancer of the uterine cervix Br J Radiol 11 1938 809 824
77. C Haie-Meder, R Pötter, E Van Limbergen, E Briot, M De Brabandere, J Dimopoulos et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV Radiother Oncol 74 3 2005 235 245
78. R Pötter, C Haie-Meder, E Van Limbergen, I Barillot, M De Brabandere, J Dimopoulos et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology Radiother Oncol 78 1 2006 67 77
79. C Haie-Meder, R Mazeron, O Verezesan, I Dumas, L Monnier, S Vieillot et al. [Three-dimensional brachytherapy optimization techniques in the treatment of patients with cervix cancer] Cancer Radiother 13 6-7 2009 520 524 In French.
80. AN Viswanathan, CL Creutzberg, P Craighead, M McCormack, T Toita, K Narayan et al. International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG) Int J Radiat Oncol Biol Phys 82 1 2012 250 255
81. R Pötter, TH Knocke, C Fellner, M Baldass, A Reinthaller, H Kucera Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations Cancer Radiother 4 2 2000 159 172
82. DN Sharma, GK Rath, S Thulkar, S Kumar, V Subramani, PK Julka High-dose rate interstitial brachytherapy using two weekly sessions of 10 Gy each for patients with locally advanced cervical carcinoma Brachytherapy 10 3 2011 242 248
83. CA Perez, PW Grigsby, H Castro-Vita, MA Lockett Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy Int J Radiat Oncol Biol Phys 32 5 1995 1275 1288
84. RM Lanciano, TF Pajak, K Martz, GE Hanks The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study Int J Radiat Oncol Biol Phys 25 3 1993 391 397
85. YS Kim, SS Shin, JH Nam, YT Kim, YM Kim, JH Kim et al. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer Gynecol Oncol 108 1 2008 195 200
86. R Lanciano, A Calkins, BN Bundy, G Parham, JA Lucci 3rd, DH Moore et al. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a Gynecologic Oncology Group study J Clin Oncol 23 33 2005 8289 8295
87. National Cancer Institute Clinical Trials Home Page Web site: www.cancer.gov/clinicaltrials
88. A Dueñas-González, JJ Zarbá, F Patel, JC Alcedo, S Beslija, L Casanova et al. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix J Clin Oncol 29 13 2011 1678 1685
89. LH Barraclough, R Swindell, JE Livsey, RD Hunter, SE Davidson External beam boost for cancer of the cervix uteri when intracavitary therapy cannot be performed Int J Radiat Oncol Biol Phys 71 3 2008 772 778
90. JH Hong, CS Tsai, CH Lai, TC Chang, CC Wang, HH Chou et al. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy Int J Radiat Oncol Biol Phys 60 1 2004 249 257
91. D Bodurka-Bevers, M Morris, PJ Eifel, C Levenback, MW Bevers, KR Lucas et al. Posttherapy surveillance of women with cervical cancer: an outcomes analysis Gynecol Oncol 78 2 2000 187 193
92. KC Lim, RE Howells, AS Evans The role of clinical follow up in early stage cervical cancer in South Wales BJOG 111 12 2004 1444 1448
93. AH Wolfson, X Wu, C Takita, H Shao, C Luo, M Watzich et al. A novel applicator for low-dose-rate brachytherapy of gynecological cancers Int J Gynecol Cancer 13 4 2003 532 540
94. L Elit, AW Fyles, MC Devries, TK Oliver, M Fung-Kee-Fung Follow-up for women after treatment for cervical cancer: a systematic review Gynecol Oncol 114 3 2009 528 535
95. BJ Monk, HQ Huang, D Cella, HJ Long 3rd Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study J Clin Oncol 23 21 2005 4617 4625
96. DH Moore, JA Blessing, RP McQuellon, HT Thaler, D Cella, J Benda et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study J Clin Oncol 22 15 2004 3113 3119
97. BJ Monk, MW Sill, DS McMeekin, DE Cohn, LM Ramondetta, CH Boardman et al. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study J Clin Oncol 27 28 2009 4649 4655
98. HJ Long, BN Bundy, EC Grendys, JA Benda, DS McMeekin, J Sorosky et al. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study J Clin Oncol 23 21 2005 4626 4633
99. E Chow, L Zeng, N Salvo, K Dennis, M Tsao, S Lutz Update on the systematic review of palliative radiotherapy trials for bone metastases Clin Oncol (R Coll Radiol) 24 2 2012 112 124
100. PJ Eifel, A Jhingran, J Brown, C Levenback, H Thames Time course and outcome of central recurrence after radiation therapy for carcinoma of the cervix Int J Gynecol Cancer 16 3 2006 1106 1111
101. H Fagundes, CA Perez, PW Grigsby, MA Lockett Distant metastases after irradiation alone in carcinoma of the uterine cervix Int J Radiat Oncol Biol Phys 24 2 1992 197 204
102. JR van Nagell, W Rayburn, ES Donaldson, M Hanson, EC Gay, J Yoneda et al. Therapeutic implications of patterns of recurrence in cancer of the uterine cervix Cancer 44 6 1979 2354 2361
103. Y Eralp, P Saip, B Sakar, S Kucucuk, A Aydiner, M Dincer et al. Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix Int J Gynecol Cancer 13 4 2003 497 504
104. M Friedlander, M Grogan, U.S. Preventative Services Task Force Guidelines for the treatment of recurrent and metastatic cervical cancer Oncologist 7 4 2002 342 347
105. PW Grigsby Radiotherapy for pelvic recurrence after radical hysterectomy for cervical cancer Radiat Med 23 5 2005 327 330
106. CJ Haasbeek, AL Uitterhoeve, J van der Velden, DG González, LJ Stalpers Long-term results of salvage radiotherapy for the treatment of recurrent cervical carcinoma after prior surgery Radiother Oncol 89 2 2008 197 204
107. B Piura, A Rabinovich, M Friger Recurrent cervical carcinoma after radical hysterectomy and pelvic lymph node dissection: a study of 32 cases Eur J Gynaecol Oncol 29 1 2008 31 36
108. YS Lee, YS Kim, JH Kim, SD Ahn, SW Lee, SS Shin et al. Feasibility and outcome of concurrent chemoradiotherapy for recurrent cervical carcinoma after initial surgery Tumori 96 4 2010 553 559
109. 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer Anticancer Res 21 4B 2001 2957 2961
110. A Husain, T Akhurst, S Larson, K Alektiar, RR Barakat, DS Chi A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration Gynecol Oncol 106 1 2007 177 180
111. JB Unger, JJ Ivy, P Connor, A Charrier, MR Ramaswamy, FL Ampil et al. Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women Gynecol Oncol 94 1 2004 212 216
112. LJ Havrilesky, TZ Wong, AA Secord, A Berchuck, DL Clarke-Pearson, EL Jones The role of PET scanning in the detection of recurrent cervical cancer Gynecol Oncol 90 1 2003 186 190
113. HH Chung, H Jo, WJ Kang, JW Kim, NH Park, YS Song et al. Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence Gynecol Oncol 104 3 2007 529 534
114. A Pallardy, C Bodet-Milin, A Oudoux, L Campion, E Bourbouloux, C Sagan et al. Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma Eur J Nucl Med Mol Imaging 37 7 2010 1270 1278
115. E Mittra, T El-Maghraby, CA Rodriguez, A Quon, IR McDougall, SS Gambhir et al. Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma Eur J Nucl Med Mol Imaging 36 12 2009 1952 1959
116. K Kitajima, K Murakami, E Yamasaki, Y Domeki, Y Kaji, K Sugimura Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer Eur Radiol 18 10 2008 2040 2047
117. LA Ruth-Sahd, KD Zulkosky Cervical cancer: caring for patients undergoing total pelvic exenteration Crit Care Nurse 19 1 1999 46 57
118. M Höckel, N Dornhöfer Pelvic exenteration for gynaecological tumours: achievements and unanswered questions Lancet Oncol 7 10 2006 837 847
119. Y Niibe, M Kenjo, T Kazumoto, K Michimoto, M Takayama, C Yamauchi et al. Multi-institutional study of radiation therapy for isolated para-aortic lymph node recurrence in uterine cervical carcinoma: 84 subjects of a population of more than 5,000 Int J Radiat Oncol Biol Phys 66 5 2006 1366 1369
120. C Uzan, E Vincens, C Balleyguier, S Gouy, P Pautier, P Duvillard et al. Outcome of patients with incomplete resection after surgery for stage IB2/II cervical carcinoma with chemoradiation therapy Int J Gynecol Cancer 20 3 2010 379 384
121. SW Chen, JA Liang, SN Yang, FJ Lin Postoperative radiotherapy for patients with invasive cervical cancer following treatment with simple hysterectomy Jpn J Clin Oncol 33 9 2003 477 481
122. MP Hopkins, WA Peters, W Andersen, GW Morley Invasive cervical cancer treated initially by standard hysterectomy Gynecol Oncol 36 1 1990 7 12
123. F Amant, L Brepoels, MM Halaska MJ Gziri, KV Calsteren Gynaecologic cancer complicating pregnancy: an overview Best Pract Res Clin Obstet Gynaecol 24 1 2010 61 79
124. B Duggan, LI Muderspach, LD Roman, JP Curtin, G d'Ablaing 3rd, CP Morrow Cervical cancer in pregnancy: reporting on planned delay in therapy Obstet Gynecol 82 4 Pt 1 1993 598 602
125. J Nevin, R Soeters, K Dehaeck, B Bloch, L Van Wyk Advanced cervical carcinoma associated with pregnancy Int J Gynecol Cancer 3 1 1993 57 63
126. MI Hunter, K Tewari, BJ Monk Cervical neoplasia in pregnancy. Part 2: current treatment of invasive disease Am J Obstet Gynecol 199 1 2008 10 18
127. K Tewari, F Cappuccini, A Gambino, MF Kohler, S Pecorelli, PJ DiSaia Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy: a report of two cases and review of issues specific to the management of cervical carcinoma in pregnancy including planned delay of therapy Cancer 82 8 1998 1529 1534
128. A Boyd, V Cowie, C Gourley The use of cisplatin to treat advanced-stage cervical cancer during pregnancy allows fetal development and prevents cancer progression: report of a case and review of the literature Int J Gynecol Cancer 19 2 2009 273 276